Uwe Bicker - Sanofi Insider

SNYNF -- USA Stock  

USD 85.45  2.21  2.52%

  Director
Mr. Uwe Bicker was Independent Director of Sanofi SA since May 14 2008. He is also Member of the Strategy Committee of the Company. Additionally he serves as Member of the Supervisory Board of Foundation Aventis and of Future Capital AG as well as Member of the Consulting Committee of Morgan Stanley. As of 2011 he was the Dean at the Medical Faculty of the Heidelberg University where he was Professor since 1983 and he also became Managing Director at the University Clinic of Mannheim in 2011. He is also an Honorary Senator of Heidelberg University and an Honorary Doctor of the Klausenburg University. During his professional career Mr. Bicker was also appointed as Trustee of Fondation Aventis. Between 1975 and 1994 he held various positions at Boehringer Mannheim GmbH and from 1994 to 2004 he held various positions at Hoechst group. Until 2012 Mr. Bicker also served as Chairman of the Supervisory Board of Siemens Healthcare Diagnostics Holding GmbH Vice Chairman of the Supervisory Board of Epigenomics AG and of Definiens AG. He is a Physician and holds a Doctorate in Chemistry and Medicine.
Age: 69  Director Since 2008  Ph.D    
33 1 53 77 40 00  http://www.sanofi.com

Management Efficiency

The company has return on total asset (ROA) of 3.78 % which means that it generated profit of $3.78 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.91 % meaning that it generated $5.91 on every $100 dollars invested by stockholders.
The company has accumulated 33.72 B in total debt with debt to equity ratio (D/E) of 51.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sanofi has Current Ratio of 1.25 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Andreas PlantaNovartis AG
2006
Raul AlvarezEli Lilly and Company
2009
Pierre LandoltNovartis AG
1996
Ann CairnsAstraZeneca PLC
2014
Michael EskewEli Lilly and Company
2008
Mark McClellanJohnson Johnson
2013
Mary ColemanJohnson Johnson
2003
Paul BulckeRoche Holding AG
2011
Julie BrownRoche Holding AG
2016
DeAnne JuliusRoche Holding AG
2002
William PerezJohnson Johnson
2007
Marcus WallenbergAstraZeneca PLC
1999
Richard LiftonRoche Holding AG
2015
Vindi BangaGlaxoSmithKline plc
2017
Hans WijersGlaxoSmithKline plc
2013
Peter VoserRoche Holding AG
2011
Dimitri AzarNovartis AG
2012
Tim JacksonSmithAstraZeneca PLC
2015
Richard LiftonRoche Holding AG
2015
Franklyn PrendergastEli Lilly and Company
1995
Sherilyn McCoyAstraZeneca PLC
2017

Entity Summary

It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1 Aubagio, an oral immunomodulatory and Lemtrada, a monoclonal antibody to treat multiple sclerosis. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi is traded on OTC Market in USA.Sanofi (SNYNF) is traded on OTC Market in USA. It is located in 54, Rue La Bo?tie and employs 106,566 people.

Sanofi Leadership Team

Dominique Carouge, Executive Vice President - Head of Business Transformation Member of the Executive Committee
Emmanuel Babeau, Independent Director
Claudie Haignere, Independent Director
Olivier Brandicourt, CEO, Director and Member of Strategy Committee
Pascale Witz, Executive Vice President - Global Divisions & Strategic Commercial Development, Member of the Executive Committee and the Global Leadership Team
Serge Weinberg, Chairman, Interim CEO, Chairman of Appointments and Governance Committee and Chairman of Strategy Committee
Suresh Kumar, Executive Vice President - External Affairs, Member of the Executive Committee and Global Leadership Team
Kathleen Tregoning, Executive Vice President External Affairs; Member of the Executive Committee
Sebastien Martel, Vice President - Investor Relations and Member of the Global Leadership Team
William Sibold, Executive Vice President Sanofi Genzyme; Member of the Executive Committee
Peter Guenter, Executive Vice President - Global Commercial Operations, Member of the Executive Committee and the Global Leadership Team
Fabienne Lecorvaisier, Director
George Grofik, Vice President of Investor Relations
Karen Linehan, Member of the Executive Board, Member of the Management Board, Senior Vice President General Counsel
David Loew, Member of the Global LeaderShip Team, Senior Vice President - Commercial Operations Europe
Muzammil Mansuri, Executive Vice President Strategy & Business Development, Member of the Executive Committee and the Senior Leadership Team
Klaus Pohle, Independent Director
John Reed, President - Global Research & Development, Member of the Executive Committee
Diane Souza, Independent Director
Bernard Charles, Independent Director
Carole Piwnica, Independent Director
Elias Zerhouni, President - Global Research & Development, Member of the Executive Committee and the Global Leadership Team
Ameet Nathwani, Executive Vice President Group Chief Medical Officer, Member of the Executive Committee
Philippe Luscan, Senior Vice President - Industrial Affairs, Member of the Executive Committee and the Global Leadership Team
Roberto Pucci, Senior Vice President - Human Resources, Member of the Executive Committee and the Global Leadership Team
DavidAlexandre Gros, Executive Vice President Chief Strategy Officer and Member of the Executive Committee
Olivier Charmeil, Senior Vice President - Vaccines, Member of the Executive Committee and Global Leadership Team
Melanie Lee, Independent Director
Igor Landau, Director
Patrick Kron, Independent Director
Stefan Oelrich, Executive Vice President - Diabetes & Cardiovascular, Member of the Executive Committee
Bonnie Bassler, Director
Thomas Suedhof, Independent Director
Laurent Attal, Director
JeanRene Fourtou, Independent Director
Gerard Kemmel, Independent Director
SuetFern Lee, Independent Director
Carsten Hellmann, Executive Vice President - Animal Health and Member of the Global Leadership Team
David Meeker, Member of the Executive Board and Executive Vice President - Genzyme and Member of the Global Leadership Team
Christian Mulliez, Director
Robert Castaigne, Independent Director
Alan Main, Executive Vice President Consumer Healthcare; Member of the Executive Committee
Suet Lee, Independent Director
Jerome Contamine, Executive Vice President - CFO, Member of the Executive Committee and Global Leadership Team
Uwe Bicker, Independent Director

Stock Performance Indicators

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Bollinger Bands
Currently Active Assets on Macroaxis
CRM   
Purchased a lot of shares of
3 days ago
Traded for 156.0
CRM   
Purchased a lot of shares of
3 days ago
Traded for 156.0
F   
Purchased over 300 shares of
3 days ago
Traded for 9.81
C   
Purchased over 40 shares of
3 days ago
Traded for 74.735
GM   
Purchased over 70 shares of
3 days ago
Traded for 36.08
Also please take a look at World Market Map. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Search macroaxis.com